CLINICAL_TRIALS
trial_result
· 2014-06-06
Clinical Trial Update: Simvastatin Therapy in Smith-Lemli-Opitz Syndrome [Phase 2]
Summary
Phase 2 clinical trial evaluating simvastatin therapy for Smith-Lemli-Opitz Syndrome completed; results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Forbes Porter, M.D. | Conditions: Smith-Lemli-Opitz Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2014-06-06